Brief: Summit Healthcare And YS Biopharma Announce Effectiveness Of Registration Statement And Extraordinary General Meeting Date For Proposed Business Combination
08/02/2023 14:16
Feb 8 (Reuters) - Summit Healthcare Acquisition Corp
SMIH.O :
* SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA
ANNOUNCE
EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY
GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
Source text for Eikon: ID:nPn9v1rQJa
Further company coverage: SMIH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing